Fennec Pharmaceuticals Inc. financial data

Symbol
FENC on Nasdaq
Location
Po Box 13628, 68 Tw Alexander Drive, Research Triangle Park, NC
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Former names
ADHEREX TECHNOLOGIES INC (to 8/14/2014)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 661 % +23%
Debt-to-equity -1.54K % -296%
Return On Equity 29.9 % -88.8%
Return On Assets -2.08 % +97.7%
Operating Margin 3.41 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.4M shares +2.99%
Common Stock, Shares, Outstanding 27.4M shares +2.96%
Entity Public Float 138M USD +40.4%
Common Stock, Value, Issued 145M USD +1.31%
Weighted Average Number of Shares Outstanding, Basic 27.4M shares +2.91%
Weighted Average Number of Shares Outstanding, Diluted 27.4M shares +2.91%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 49.3M USD +7.05%
Research and Development Expense 289K USD +105%
Selling and Marketing Expense 18.4M USD +36%
General and Administrative Expense 25.8M USD +41.1%
Operating Income (Loss) 1.68M USD -412%
Nonoperating Income (Expense) -2.82M USD +10.1%
Net Income (Loss) Attributable to Parent -1.13M USD +94.4%
Earnings Per Share, Basic -0.09 USD/shares +88.3%
Earnings Per Share, Diluted -0.09 USD/shares +88.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 40.3M USD +225%
Other Assets, Current 546K USD +2630%
Assets, Current 58M USD +191%
Operating Lease, Right-of-Use Asset 29K USD
Other Assets, Noncurrent 956K USD
Assets 58.9M USD +195%
Accounts Payable, Current 3.87M USD +31.5%
Accrued Liabilities, Current 3.31M USD +248%
Contract with Customer, Liability, Current 248K USD
Liabilities, Current 7.44M USD +90%
Contract with Customer, Liability, Noncurrent 24.6M USD
Operating Lease, Liability, Noncurrent 2K USD
Liabilities 64.1M USD +117%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.24M USD 0%
Retained Earnings (Accumulated Deficit) -218M USD -201%
Stockholders' Equity Attributable to Parent -5.17M USD +50.9%
Liabilities and Equity 58.9M USD +195%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 39M USD
Net Cash Provided by (Used in) Financing Activities -1.13M USD -687%
Common Stock, Shares, Issued 27.4M shares +2.96%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 37.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 40.3M USD +225%
Deferred Tax Assets, Valuation Allowance 40.7M USD +20%
Deferred Tax Assets, Gross 40.7M USD +20%
Operating Lease, Liability 7K USD
Lessee, Operating Lease, Liability, to be Paid 5K USD
Operating Lease, Liability, Current 7K USD -66.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 5K USD
Deferred Tax Assets, Operating Loss Carryforwards 37.1M USD +23.8%
Deferred Tax Assets, Net of Valuation Allowance 26K USD 0%